MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corporation (NASDAQ: EXAS) (“Exact Sciences”), a leading provider of cancer screening and diagnostic tests, today announced that its stockholders voted ...
The life sciences tools and services sector is back in focus after Merck KGaA (MKGAF) agreed to acquire Bio-Techne (TECH) for $73 per share in cash, valuing the deal at an enterprise value of around ...
Cassava Sciences (SAVA) said it will change its name to Filana Therapeutics, reflecting its focus on developing drugs that target the filamin A protein to treat central nervous system disorders. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results